BIO 2015 in Philadelphia next week-June 15-18
We will be attending the BIO International Convention in Philadelphia next week. Sign up now to receive life science industry news.
Slower Growth in Diagnostics Stocks Except for NexGen Sequencing and Molecular
New technologies in diagnostics and tools are driving growth: NexGen sequencing, molecular and "point-of-care" testing platforms and veterinary testing. M&A and consolidation should continue. The sector is a laggard due to slowing sales and earnings growth vs forecasts. Rayno Clinical...
Biotech ETF Trending Shows Shift To Speculative Stocks: XBI
Updated 6/10 Biotech ETFs lag overall in 1.4% rally. Materials, financials and technology lead. Large cap biotechs doing well. Rayno portfolio winners today: ALXN, BIIB, GILD, RHHBY etc Rapid Fire Re-Balancing of ETFs into More Speculative Names Is the Tail Wagging the Dog? We have published a...
ASCO Rally Fades But Spec Stocks Rock: FCSC,RXDX
ASCO Week in Review- Rayno Biopharmaceutical Stocks The market action over the past week focused on speculative stocks rather than the overall biopharmaceutical sector. Major ETFs over five days were mixed with the smaller cap XBI up over 1%, the IBB flat and the FBT trailed down 0.7%. Many of...
ASCO 2015 Biotech Movers Day Two: FCSC, JUNO, RXDX
Update-1 BLUE Drops 1.96% and 1.77% After Hours 6/3 In the bubbly CAR-T world bluebird bio (BLUE) and Celgene announced a deal for for development of product candidates for B-cell maturation antigen (BMCA) utilizing bluebird bios's gene therapy technology to modify a patient's own T-Cells to...